title: T790M is associated with a favorable prognosis in Japanese patients treated with an EGFR-TKI.
authors.forename: Hidetaka
authors.initials: H
authors.lastname: Uramoto
authors.forename: Seiji
authors.initials: S
authors.lastname: Yano
authors.forename: Fumihiro
authors.initials: F
authors.lastname: Tanaka
mesh_terms: D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000235:genetics*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D019859:Proto-Oncogene Proteins c-met / Q000037:antagonists & inhibitors*
chemical_list: D047428:Protein Kinase Inhibitors; D066246:ErbB Receptors; D019859:Proto-Oncogene Proteins c-met